Lower incidence of hospital-treated infections in infants under 3 months of age vaccinated with BCG.

[1]  G. Toldi,et al.  The association between parental and neonatal BCG vaccination and neonatal T helper 17 cell expansion. , 2022, Vaccine.

[2]  P. Aaby,et al.  Retesting the hypothesis that early Diphtheria-Tetanus-Pertussis vaccination increases female mortality: An observational study within a randomised trial. , 2021, Vaccine.

[3]  Fred N. Kiwanuka,et al.  BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial , 2021, The Lancet. Infectious diseases.

[4]  P. Aaby,et al.  Diphtheria-tetanus-pertussis (DTP) vaccine is associated with increased female-male mortality rate ratios. A meta-analysis of studies of DTP administered before and after measles vaccine. , 2020, The Journal of infectious diseases.

[5]  T. Tapiainen,et al.  Change in respiratory syncytial virus seasonality in Finland , 2019, Acta paediatrica.

[6]  L. Joosten,et al.  INTERACTING NON-SPECIFIC IMMUNOLOGICAL EFFECTS OF BCG AND Tdapf VACCINATIONS: AN EXPLORATIVE RANDOMIZED TRIAL. , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  A. Rodrigues,et al.  Early BCG Vaccination, Hospitalizations, and Hospital Deaths: Analysis of a Secondary Outcome in 3 Randomized Trials from Guinea-Bissau , 2018, The Journal of infectious diseases.

[8]  O. Pryds,et al.  BCG Vaccination at Birth and Rate of Hospitalization for Infection Until 15 Months of Age in Danish Children: A Randomized Clinical Multicenter Trial. , 2019, Journal of the Pediatric Infectious Diseases Society.

[9]  L. Joosten,et al.  Non-specific effects of vaccines: Current evidence and potential implications. , 2018, Seminars in immunology.

[10]  J. Ollgren,et al.  Increase in Childhood Nontuberculous Mycobacterial Infections After Bacille Calmette-Guérin Coverage Drop: A Nationwide, Population-Based Retrospective Study, Finland, 1995–2016 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  T. Kilpi,et al.  Effectiveness of pneumococcal Haemophilus influenzae protein D conjugate vaccine against pneumonia in children: A cluster-randomised trial. , 2018, Vaccine.

[12]  A. Palmu,et al.  Register-Based Ecologic Evaluation of Safety Signals Related to Pneumococcal Conjugate Vaccine in Children , 2018, Current drug safety.

[13]  J. Ollgren,et al.  Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare. , 2017, Vaccine.

[14]  J. Mcnicholl,et al.  Risk of Nontargeted Infectious Disease Hospitalizations Among US Children Following Inactivated and Live Vaccines, 2005–2014 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Rodrigues,et al.  Early BCG-Denmark and Neonatal Mortality Among Infants Weighing <2500 g: A Randomized Controlled Trial , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  M. Netea,et al.  Whole Blood Profiling of Bacillus Calmette–Guérin-Induced Trained Innate Immunity in Infants Identifies Epidermal Growth Factor, IL-6, Platelet-Derived Growth Factor-AB/BB, and Natural Killer Cell Activation , 2017, Front. Immunol..

[17]  T. Kilpi,et al.  Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study , 2017, PloS one.

[18]  S. Rowland-Jones,et al.  Sex-Differential Non-Vaccine-Specific Immunological Effects of Diphtheria-Tetanus-Pertussis and Measles Vaccination. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[19]  J. Sterne,et al.  Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review , 2016, British Medical Journal.

[20]  O. Pryds,et al.  BCG vaccination at birth and early childhood hospitalisation: a randomised clinical multicentre trial , 2016, Archives of Disease in Childhood.

[21]  O. Pryds,et al.  Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial , 2016, Pediatric Research.

[22]  M. Korppi,et al.  Orthopedic Complications in Former Bacillus Calmette-GuÉrin Osteitis Patients , 2016, The Pediatric infectious disease journal.

[23]  P. Aaby,et al.  Oral Polio Vaccination and Hospital Admissions With Non-Polio Infections in Denmark: Nationwide Retrospective Cohort Study , 2015, Open forum infectious diseases.

[24]  M. Netea,et al.  BCG Vaccination Enhances the Immunogenicity of Subsequent Influenza Vaccination in Healthy Volunteers: A Randomized, Placebo-Controlled Pilot Study. , 2015, The Journal of infectious diseases.

[25]  P. Aaby,et al.  Early BCG vaccine to low-birth-weight infants and the effects on growth in the first year of life: a randomised controlled trial , 2015, BMC Pediatrics.

[26]  T. Kilpi,et al.  Pneumococcal Conjugate Vaccine and Clinically Suspected Invasive Pneumococcal Disease , 2015, Pediatrics.

[27]  M. Netea,et al.  Heterologous Immunological Effects of Early BCG Vaccination in Low-Birth-Weight Infants in Guinea-Bissau: A Randomized-controlled Trial , 2014, The Journal of infectious diseases.

[28]  M. Netea,et al.  Trained immunity: consequences for the heterologous effects of BCG vaccination. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[29]  P. Aaby,et al.  Live vaccine against measles, mumps, and rubella and the risk of hospital admissions for nontargeted infections. , 2014, JAMA.

[30]  T. Kilpi,et al.  Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial , 2012, The Lancet.

[31]  J. Ollgren,et al.  Influenza-associated hospitalisations in Finland from 1996 to 2010: unexpected age-specific burden during the influenza A(H1N1)pdm09 pandemic from 2009 to 2010. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[32]  R. Sund.  Quality of the Finnish Hospital Discharge Register: A systematic review , 2012, Scandinavian journal of public health.

[33]  A. Rodrigues,et al.  Testing the hypothesis that diphtheria–tetanus–pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countries , 2012, BMJ Open.

[34]  T. Sørensen,et al.  Smallpox vaccination and all-cause infectious disease hospitalization: a Danish register-based cohort study. , 2011, International journal of epidemiology.

[35]  M. Sodemann,et al.  Vaccination status and sequence of vaccinations as risk factors for hospitalisation among outpatients in a high mortality country. , 2011, Vaccine.

[36]  P. Aaby,et al.  Diphtheria-tetanus-pertussis vaccine administered simultaneously with measles vaccine is associated with increased morbidity and poor growth in girls. A randomised trial from Guinea-Bissau. , 2011, Vaccine.

[37]  Tea Nieminen,et al.  Rokotuksista ilmoitetut haittaepäilyt vuonna 2007 , 2008 .

[38]  L. Moulton,et al.  Non-specific effects of diphtheria tetanus pertussis vaccination on child mortality in Cebu, The Philippines. , 2007, International journal of epidemiology.

[39]  P. Aaby,et al.  Bacillus Calmette-Guérin vaccination and infant mortality , 2006, Expert review of vaccines.

[40]  E. Salo.  BCG in Finland: changing from a universal to a selected programme. , 2006, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[41]  S. Rapola,et al.  Rokotusohjelma uudistuu vuoden 2005 alussa , 2004 .

[42]  H. Whittle,et al.  BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? , 2003, Vaccine.

[43]  A. Tosteson,et al.  A cost-effectiveness analysis of universal versus selective immunization with Mycobacterium bovis bacille Calmette-Guérin in Finland. , 2003, The International Journal of Tuberculosis and Lung Disease.

[44]  M. Tala-Heikkilä.  [Is the BCG--Bacillus Calmette-Guérin transferred to history?]. , 2002, Duodecim; laaketieteellinen aikakauskirja.